Golin identifies the top 10 trends that will affect how organizations build and protect their reputations heading into 2025.

Anthony Olson was told that he’d die without the treatment and to ignore a negative biopsy. He’s one of many patients who may have received harmful or unnecessary treatments from Montana oncologist Dr ...

From Pfizer to AstraZeneca and the Omnicom-IPG Merger, the industry has seen a number of executive moves during this year.

Corcept’s first hypercortisolism awareness and screening campaign highlights the prevalence of what was long thought to be a very rare condition.

The healthcare technology solutions firm is saying goodbye to CEO William J. Febbo, who is leaving the company effective ...

The Biden administration hasn’t delivered on its goals of measuring the public health impact of abortion bans. Experts say it ...

The first procedure was listed as “colonoscopy and biopsy,” while the second was listed as “colonoscopy w/lesion removal.” ...

It seems simple: Require hospitals and insurers to post their negotiated prices for most health care services and — bingo — competition follows, yielding lower costs for consumers. But nearly four ...

A recent survey titled “Behind the Screens: Refining your 2025 Media Mix,” conducted by Swoop/MM+M, highlights how healthcare marketers view different video platforms for engaging audiences and the ...

Mental health awareness has surged in recent years, but now TikTokers are bringing attention to “introspection burnout” — or feeling emotionally drained from therapy.

Big moments filled pharma marketing’s 2024. Pfizer made the leap into the Super Bowl, a number of campaigns won big in Cannes ...

Although Novo underscored that patients in the trial achieved up to 22.7% of weight loss with CagriSema, analysts previously said they were hoping to see whether it would significantly beat Lilly’s ...